Cargando…
Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma
BACKGROUND: Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young infants. For these reasons, we have developed a strategy of bridge intravenous single agent chemotherapy to postpone IA chemotherapy in these children PROCEDURE: Neonates and young infants w...
Autores principales: | Gobin, Y. Pierre, Dunkel, Ira J., Marr, Brian P., Francis, Jasmine H., Brodie, Scott E., Abramson, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445577/ https://www.ncbi.nlm.nih.gov/pubmed/23028521 http://dx.doi.org/10.1371/journal.pone.0044322 |
Ejemplares similares
-
Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma
por: Abramson, David H., et al.
Publicado: (2016) -
Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-arterial Chemotherapy for Retinoblastoma
por: Marr, Brian, et al.
Publicado: (2010) -
Risk Factors for Severe Neutropenia following Intra-Arterial Chemotherapy for Intra-Ocular Retinoblastoma
por: Dunkel, Ira J., et al.
Publicado: (2014) -
Intraocular Hemorrhage After Intra-Arterial Chemotherapy for Retinoblastoma in Sickle Cell Trait
por: Abramson, David H, et al.
Publicado: (2012) -
Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy
por: Francis, Jasmine H., et al.
Publicado: (2018)